Amanda J. Redig, M.D., Ph.D. is InduPro’s Chief Medical Officer and leads the clinical and translational medicine development of the InduPro pipeline. As a medical oncologist and oncology drug developer, she brings extensive experience spanning academic medicine, drug development in both Pharma and Biotech, and life sciences investing.
Dr. Redig’s focus on oncology drug development comes from her deep commitment to oncology patients, having been a member of the faculty at the Dana-Farber Cancer Institute and Harvard Medical School as both a thoracic oncologist and inpatient oncology hospitalist. She has previously served as Senior Vice President and Head of Clinical Development at HotSpot Therapeutics, where she led Phase 1 clinical development for its first-in-human immuno-oncology program. Before joining HotSpot, Dr. Redig was a Principal and member of the Investment team at Blackstone Life Sciences, where she supported the sourcing and structuring of life science investments, including multiple oncology transactions. Prior to that, she was Executive Medical Director and Head of Translational Science, Oncology at Takeda Pharmaceuticals, where she helped grow and lead its translational sciences organization supporting a diverse oncology pipeline of more than 40 assets from preclinical discovery through clinical development and post-approval life cycle management, including multiple R&D partnerships with both academic centers and biotech companies.
Dr. Redig began her career in academic medicine as a thoracic oncologist and translational investigator at the Dana-Farber Cancer Institute, where she was an active participant in clinical trial enrollment, including the development of investigator-sponsored studies. She served as principal investigator or sub-investigator across a broad thoracic oncology clinical trial portfolio, including early studies of PD-1/PD-L1 inhibitors and targeted therapies and worked closely on early osimertinib clinical and translational development.
She earned her M.D. and Ph.D. in Cancer Biology from Northwestern University Feinberg School of Medicine before completing her residency in internal medicine at Brigham and Women’s Hospital and her fellowship in medical oncology in the Dana-Farber/Partners Cancer Care fellowship program. She received her BS in biochemistry from the University of Arizona and is an author on more than 40 peer-reviewed publications.